Cargando…

Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions

Pharmacogenotyping is applied to determine the hereditable component of a patient's susceptibility to experience therapy failure and/or adverse drug reactions (ADRs). We present the case of a female patient diagnosed with breast cancer and treated with tamoxifen as recurrence therapy who experi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeiziner, Chiara, Stäuble, Céline K, Lampert, Markus L, Hersberger, Kurt E, Meyer zu Schwabedissen, Henriette E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903951/ https://www.ncbi.nlm.nih.gov/pubmed/33642872 http://dx.doi.org/10.2147/PGPM.S285807

Ejemplares similares

Pharmacogenetics in Pharmaceutical Care—Piloting an Application-Oriented Blended Learning Concept
por: Stäuble, Céline K., et al.
Publicado: (2021)

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
por: Bollinger, Anna, et al.
Publicado: (2023)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting
por: Stäuble, Céline K., et al.
Publicado: (2022)

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
por: Jeiziner, Chiara, et al.
Publicado: (2022)

Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service
por: Jeiziner, Chiara, et al.
Publicado: (2023)

HLA‐associated adverse drug reactions ‐ scoping review
por: Jeiziner, Chiara, et al.
Publicado: (2021)

Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial
por: Stäuble, Céline K., et al.
Publicado: (2021)

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy
por: Wiss, Florine M., et al.
Publicado: (2023)

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene
por: Stäuble, Céline K., et al.
Publicado: (2022)

Pharmacogenetic information in Swiss drug labels – a systematic analysis
por: Jeiziner, C., et al.
Publicado: (2020)

Pharmacogenetic Analysis of Voriconazole Treatment in Children
por: Tilen, Romy, et al.
Publicado: (2022)

Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
por: Wittwer, Nina L, et al.
Publicado: (2022)

Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2015)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

Expression and Function of Organic Anion Transporting Polypeptides in the Human Brain: Physiological and Pharmacological Implications
por: Schäfer, Anima M., et al.
Publicado: (2021)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Tamoxifen side effects: pharmacogenetic and clinical approach in Mexican mestizos
por: Rangel-Méndez, Jorge-Aarón, et al.
Publicado: (2019)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
por: Piatkov, Irina, et al.
Publicado: (2012)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA
por: Vizeli, Patrick, et al.
Publicado: (2017)

Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review
por: Merino, Diane, et al.
Publicado: (2022)

Pharmacogenetics for severe adverse drug reactions induced by molecular‐targeted therapy
por: Udagawa, Chihiro, et al.
Publicado: (2020)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Pharmaceutical Discharge Management: Implementation in Swiss Hospitals Compared to International Guidelines
por: Studer, Helene, et al.
Publicado: (2021)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017?
por: Studer, Helene, et al.
Publicado: (2020)

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment
por: Lorizio, Wendy, et al.
Publicado: (2011)

Determination of risk factors for drug-related problems: a multidisciplinary triangulation process
por: Kaufmann, Carole P, et al.
Publicado: (2015)

Clinical relevance of St. John's wort drug interactions revisited
por: Nicolussi, Simon, et al.
Publicado: (2020)

Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4‐methylaminoantipyrine
por: Bachmann, Fabio, et al.
Publicado: (2021)

Various effects of repeated rifampin dosing on coproporphyrin levels in humans
por: Kinzi, Jonny, et al.
Publicado: (2023)

Real-World Efficiency of Pharmacogenetic Screening for Carbamazepine-Induced Severe Cutaneous Adverse Reactions
por: Chen, Zhibin, et al.
Publicado: (2014)

Drug-Associated Risk Tool: development and validation of a self-assessment questionnaire to screen for hospitalised patients at risk for drug-related problems
por: Kaufmann, Carole P, et al.
Publicado: (2018)

Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report
por: Meyer zu Schwabedissen, Henriette E, et al.
Publicado: (2014)

PDMS-PMOXA-Nanoparticles Featuring a Cathepsin B-Triggered Release Mechanism
por: Ehrsam, Daniel, et al.
Publicado: (2019)

Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone
por: Ali, Samina, et al.
Publicado: (2023)

Using Pharmacogenetics of Direct Oral Anticoagulants to Predict Changes in Their Pharmacokinetics and the Risk of Adverse Drug Reactions
por: Shnayder, Natalia A., et al.
Publicado: (2021)

Development of the Swiss Database for dosing medicinal products in pediatrics
por: Tilen, Romy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_im2nudl7kgcp2f2375rinra1k5